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ABSTRACT
The human 25-hydroxyvitamin D3 (25(OH)D3)
1a-hydroxylase, which is encoded by the CYP27B1
gene, catalyzes the metabolic activation of
the 25(OH)D3 into 1a,25-dihydroxyvitamin D3
(1a,25(OH)2D3), the most biologically potent vitamin
D3 metabolite. The most important regulator of
CYP27B1 gene activity is 1a,25(OH)2D3 itself, which
down-regulates the gene. The down-regulation of
the CYP27B1 gene has been proposed to involve a
negative vitamin D response element (nVDRE) that
is located  500bp upstream from transcription start
site (TSS). In this study, we reveal the existence of
two new VDR-binding regions in the distal promo-
ter, 2.6 and 3.2kb upstream from the TSS, that bind
vitamin D receptor–retinoid X receptor complexes.
Since the down regulation of the CYP27B1 gene is
tissue- and cell-type selective, a comparative study
was done for the new 1a,25(OH)2D3-responsive
regions in HEK-293 human embryonic kidney and
MCF-7 human breast cancer cells that reflect
tissues that, respectively, are permissive and non-
permissive to the phenomenon of 1a,25(OH)2D3-
mediated down-regulation of this gene. We found
significant differences in the composition of protein
complexes associated with these CYP27B1 promo-
ter regions in the different cell lines, some of which
reflect the capability of transcriptional repression of
the CYP27B1 gene in these different cells. In
addition, chromatin architecture differed with
respect to chromatin looping in the two cell lines,
as the new distal regions were differentially con-
nected with the proximal promoter. This data
explains, in part, why the human CYP27B1 gene is
repressed in HEK-293 but not in MCF-7 cells.
INTRODUCTION
The biologically active form of vitamin D, 1a,
25-dihydroxyvitamin D3 (1a,25(OH)2D3)), is required
for mineral homeostasis and skeletal integrity, as well as
controlling cell growth and diﬀerentiation in several
tissues (1). In the body, the amount of 1a,25(OH)2D3 is
tightly controlled by several enzymes that are transcribed
from genes belonging to the cytochrome P450 (CYP)
family. This gene family encodes a wide variety of
enzymes that are needed in the oxidative metabolism of
a number of endogenous and exogenous compounds (2).
One of the enzymes needed in the metabolism of
1a,25(OH)2D3 is the protein product of the CYP27B1
gene, 25-hydroxyvitamin D3 (25(OH)D3)1 a -hydroxylase.
It has an important role in the synthesis of 1a,25(OH)2D3
because it catalyzes the metabolic activation of the main
circulating form of vitamin D, 25(OH)D3, into
1a,25(OH)2D3 (3). CYP27B1 gene expression is negatively
regulated by 1a,25(OH)2D3, and this has been proposed
to occur via a negative vitamin D response element
(nVDRE), located  500bp upstream from transcription
start site (TSS) (4). The down-regulation of this gene by
1a,25(OH)2D3 is a cell-type and tissue-restricted phenom-
enon. In the body, the major expression site of the
CYP27B1 gene and its protein product, 25(OH)D3
1a-hydroxylase (CYP27B1), is the kidney. Within
this organ, both the mRNA and the protein product
have been observed to be repressed in the presence
of 1a,25(OH)2D3 in the proximal tubules only (5). The
CYP27B1 gene is also expressed in extra renal sites (6),
however the suppression of the gene by 1a,25(OH)2D3 has
been described only in a few other cell lines derived from
other tissues, such as colon-derived cells (7).
The eﬀects of 1a,25(OH)2D3 are mediated via the
vitamin D receptor (VDR), a member of the nuclear
receptor superfamily, to which 1a,25(OH)2D3 binds with
high aﬃnity. Responsiveness of a given gene to
1a,25(OH)2D3 requires that its regulatory regions contain
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direct repeats of two hexameric-core-binding motifs
spaced by 3 or 4nt (DR3 or DR4, respectively) or everted
repeats spaced by 6–9nt (ER6 and ER9, respectively)
(8,9). The hexameric sequences of the response elements of
the primary 1a,25(OH)2D3 target genes usually have the
consensus sequence RGKTSA (R¼Ao rG ,K¼Go rT ,
S¼C or G). The VDREs of most previously studied
negatively regulated genes resemble those of positively
regulated genes, although negative regulation may not
necessarily require both VDRE half sites (10–12). The
reported negative VDRE of the CYP27B1 is an exception,
because it does not contain a consensus sequence (4).
In addition, the authors proposed that the regulation of
the CYP27B1 gene involves an indirect binding of VDR to
DNA, where VDR associates with the nVDRE ligand-
dependently via another transcription factor, the VDR
interacting repressor (VDIR).
Binding of 1a,25(OH)2D3 causes a conformational
change within the ligand-binding domain of the VDR,
which modulates its interactions with nuclear proteins,
such as coactivator (CoA) and corepressor (CoR) proteins
(13). CoR proteins, such as NCoR1 (14) and SMRT/
NCoR2 (15), link non-liganded, DNA-bound VDR to
enzymes with histone deacetylase activity that cause
chromatin condensation (16). The conformational
change within VDR’s ligand-binding domain results in
the replacement of a CoR by a CoA protein of the p160
family, such as SRC-1, SRC-2 or SRC-3 (17). These CoAs
link the ligand-activated VDR to enzymes displaying
histone acetyltransferase (HAT) activity, such as CBP,
that cause chromatin relaxation by their action on
histone tails and thereby reversing the action of unli-
ganded VDR (18).
Traditionally, VDREs are thought to locate relatively
close to the TSS of 1a,25(OH)2D3 target genes. For
example, both human and rat vitamin D 24-hydroxylase
(CYP24) genes have a cluster of VDREs in their proximal
promoters (approximate position  140 to  300) (19–22).
However, recently several promoter studies have revealed
that the gene promoters may contain multiple response
elements that locate not only within proximal promoters
but also in more distal regions (23,24) and even within
coding regions (25,26). These studies have so far
concerned with only positively regulated genes. This
raises a question, whether negatively regulated genes
also have multiple response elements. Since the promoter
studies of the human CYP27B1 gene have so far been
limited to the ﬁrst 1.7kb upstream of the TSS (4,27–29), in
this study, we have extended the promoter analysis further
upstream and examined the role of distal promoter regions
to the regulation of the human CYP27B1 gene by
1a,25(OH)2D3. We analyzed 13 contiguous genomic
regions spanning 5.4kb of the CYP27B1 promoter by
chromatin immunoprecipitation (ChIP) scanning. Our
studies revealed two new 1a,25(OH)2D3-responsive
regions in the distal promoter 2.6 and 3.2kb upstream
from the TSS. Interestingly, in contrast to the nVDRE-
containing region, in silico screening revealed that both of
the new 1a,25(OH)2D3-responsive regions contained
classical VDRE sequences that were shown to directly
bind VDR–retinoid X receptor (RXR) heterodimers in a
ligand-dependent manner, when studied by gel shift
assays. Extensive ChIP analysis suggested that the new
regions have a number of similarities with the established
nVDRE in the recruitment of diﬀerent cofactors, as well
as recruiting both VDR and RXR, supporting the idea
that the putative VDREs are functional. In addition,
chromatin conformation capture (3C) analysis suggested
that the new regions are directly connected with the
TSS via chromatin looping in a ligand-dependent and
cell-speciﬁc manner.
MATERIALS AND METHODS
Cellculture
HEK-293 human embryonic kidney cells and MCF-7
human breast cancer cells were maintained in Dulbecco’s
modiﬁed Eagle medium (DMEM) containing 5% fetal
bovine serum (FBS), 2mM L-glutamine, 0.1mg/ml strep-
tomycin and 100U/ml penicillin in a humidiﬁed 95%
air–5% CO2 incubator. Before use in experimental
procedures, FBS was stripped of lipophilic compounds,
such as endogenous nuclear receptor ligands, by stirring it
with 5% activated charcoal (Sigma-Aldrich, St. Louis,
MO, USA) for 3h at room temperature. Charcoal was
then removed by centrifugation and the media was
sterilized by ﬁltration (0.2mM pore size). Prior to
mRNA or chromatin extraction, the cells were grown
overnight in phenol red-free DMEM, supplemented with
5% charcoal-stripped FBS, to reach 50–60% conﬂuency.
For ChIP assays, the cells were ﬁrst treated with 2.5mM
a-amanitin (Sigma-Aldrich) for 2h, followed by exposure
to the ligand, after the removal of the a-amanitin. The
cells were then treated with either solvent (ethanol, 0.1%
ﬁnal concentration) or with the 10nM 1a,25(OH)2D3
(kindly provided by Dr Lise Binderup, LEO Pharma,
Ballerup, Denmark, diluted in ethanol). For the RNAi
analysis, the cells were grown in phenol red-free DMEM
supplemented with 5% charcoal-stripped FBS until they
reached a conﬂuency of 40–50%.
Total RNA extraction, cDNA synthesis and real-time PCR
Total RNA was extracted using the Mini RNA Isolation
II kit (Zymo Research, HiSS Diagnostics, Freiburg,
Germany) and cDNA synthesis was performed for 1h at
378C using 1mg of total RNA as a template, in the
presence of 100pmol oligodT18 primer and 40U reverse
transcriptase (Fermentas, Vilnius, Lithuania). Real-
time quantitative PCR was performed in an IQ-cycler
(BioRad, Hercules, CA, USA) using the dye SybrGreen I
(Molecular Probes, Leiden, The Netherlands). Per reac-
tion, 0.3U Hot Start Taq polymerase (Fermentas) and
3mM MgCl2 were used and the PCR cycling conditions
were: 40 cycles of 30s at 958C, 30s at 628C and 40s at
728C. The sequences of the gene-speciﬁc primer pairs for
the human CYP24, CYP27B1, METTL1, VDIR and the
reference gene RPLP0 are listed in Table 1. PCR product
quality was monitored using post-PCR melt curve
analysis.
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HEK-293 and MCF-7 cells were transfected with either
non-speciﬁc siRNA oligomers or Stealth
TM siRNAs
targeting the VDR mRNA (Invitrogen, Carlsbad, CA,
USA) by using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA, USA) according to the instructions of
the manufacturer. The cells were seeded into 6-well plates
and grown in phenol red-free DMEM supplemented
with 5% charcoal-stripped FBS. Liposomes containing
control or VDR siRNA were formed by incubating
100pmol of each siRNA duplex with 5mlo f
Lipofectamine 2000 for 20min at room temperature in a
total volume of 500ml of phenol red-free DMEM without
antibiotics. The liposomes were added to the cells
and siRNA treatment was continued for 72h after which
the cells were treated with ethanol or 10nM
1a,25(OH)2D3 for 3h. Total RNA extraction, cDNA
synthesis and the real time quantitative PCR analysis
were done as mentioned above. Silencing of VDR at the
protein level was veriﬁed by immunoblotting using 25mg
of whole cell extract from HEK-293 or MCF-7
cells and anti-VDR antibody (sc-1008, Santa Cruz
Biotechnologies, Heidelberg, Germany). Cellular proteins
were separated using 12% SDS polyacrylamide gel
electrophoresis. The blotted proteins were detected by
using ECF Western Blotting kit according to the
manufacturer’s guidelines (GE Healthcare Europe,
Helsinki, Finland).
DNA constructs
Full-length cDNAs for human VDR (30) and human
RXRa (31) were subcloned into the T7/SV40 promoter-
driven pSG5 expression vector (Stratagene, LaJolla, CA,
USA). The same constructs were used for both T7 RNA
polymerase-driven in vitro transcription/translation of the
respective cDNAs and for viral promoter-driven over-
expression in mammalian cells. Promoter regions of the
CYP27B1 gene (see Figure 4) were cloned by PCR from
human genomic DNA using Pfu DNA polymerase
(Fermentas, Vilnius, Lithuania) and were fused with the
thymidine kinase (tk) promoter driving the ﬁreﬂy lucifer-
ase (Luc) reporter gene. All constructs were veriﬁed by
sequencing.
Gel shift analysis
VDR, RXR and VDIR proteins were generated by
coupled in vitro transcription/translation using their
respective pSG5-based cDNA expression constructs and
TNT Quick Coupled Transcription/Translation Systems
as recommended by the supplier (Promega, Madison, WI,
USA). Protein batches were quantiﬁed by test translation
in the presence of
35S-methionine (see Figure 3B). The
speciﬁc concentration of the receptor proteins was
adjusted to  4ng/ml (10ng corresponds to  0.2pmol)
after taking the individual number of methionine residues
per protein into account. Gel shift assays were performed
with 10ng of the appropriate in vitro-translated proteins.
The proteins were incubated for 15min in a total volume
of 20ml of binding buﬀer (10mM Hepes (pH 7.9), 150mM
KCl, 1mM dithiothreitol, 0.2mg/ml of poly(dI-C), 5%
glycerol). Constant amounts (1ng) of
32P-labeled double-
stranded oligonucleotides (50000c.p.m.) corresponding to
one copy of dimeric response element were then added
and incubation was continued at room temperature for
20min. Protein–DNA complexes were resolved by
electrophoresis through non-denaturing 8% (w/v) poly-
acrylamide gels in 0.5  TBE (45mM Tris, 45mM boric
acid, 1mM EDTA, pH 8.3) and quantiﬁed on an FLA-
3000 reader (Fuji, Tokyo, Japan) using Image Gauge
software (Fuji, Tokyo, Japan). Oligonucleotides were
labeled by a Klenow fragment DNA polymerase
(Fermentas, Vilnius, Lithuania)-mediated ﬁlling in reac-
tion in the presence of a nucleotide mixture containing
radiolabeled
32P a-dCTP.
ChIP assays
ChIP assays were performed as previously described (24).
The antibodies against acetylated histone H3 (AcH3, 06-
599) and H4 (AcH4, 06-866) were from Upstate
Biotechnology (Lake Placid, NY, USA). IgG (sc-2027)
and the antibodies against VDR (sc-1008), RXR (sc-553),
CBP (sc-369), phosphorylated RNA polymerase II (pPol
II, sc-13583), SRC-1 (sc-7216), SRC-2 (sc-8996), SRC-3
(sc-7216), Sin3A (sc-5378), SMRT/NCoR2 (sc-1610)
and NCoR1 (sc-8994) were obtained from Santa Cruz
Biotechnologies. The ChIP templates were analyzed
by semi-quantitative real-time PCR. For each of the 13
regions of the human CYP27B1 promoter, primer pairs
were designed (Table 2), optimized and controlled by
running PCR with 25ng genomic DNA (input) as a
template. When running immunoprecipitated DNA
(output) as a template, the following PCR proﬁle was
used: pre-incubation for 5min at 958C, 38 cycles of 30s at
958C, 30s at a primer-speciﬁc annealing temperature and
30s at 728C and one ﬁnal incubation for 10min at 728C.
The PCR products were separated by electrophoresis
through 2% agarose gels. Gel images were scanned on an
FLA-3000 reader (Fuji, Tokyo, Japan) and analyzed using
Image Gauge software (Fuji, Tokyo, Japan).
3Canalysis
Prior to 3C analysis, the ligand treatment, formaldehyde
crosslinking and collection of the HEK-293 and MCF-7
Table 1. Primer sequences used in real-time PCR
Gene Primer sequences
CYP27B1 50-CAGACAAAGACATTCATGTGGG-30
50-GTTGATGCTCCTTTCAGGTAC-30
CYP24 50-CAAACCGTGGAAGGCCTATC-30
50-AGTCTTCCCCTTCCAGGATCA-30
VDIR 50-GTGCCAACTGCACCTCAACAG-30
50-AGGTTCCGCTCTCGCACTTG-30
METTL1 50-TGCCTACGTGCTAAGAGTTGG-30
50-CTTCACTCAGGTCCTCCAGAG-30
RPLP0 50-AGATGCAGCAGATCCGCAT-30
50-GTGGTGATACCTAAAGCCTG-30
2736 Nucleic Acids Research, 2007, Vol. 35, No. 8cells were done as described for the ChIP analysis. After
harvesting of the cells by centrifugation, the cell pellets
were resuspended in 3C lysis buﬀer 1 (5mM PIPES, pH
8.0, 85mM KCl, 0.5% NP-40, protease inhibitors) and the
nuclei were collected by centrifugation and washed once
with ice-cold PBS. The pellets were resuspended in 3C lysis
buﬀer 2 (1  PBS, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS, protease inhibitors). Cellular debris was
removed by centrifugation and the lysates were divided
into 200ml aliquots. The aliquots were diluted by adding
150ml of sterile water and 40mlo f1 0   digestion buﬀer
(50mM Tris-HCl (pH 7.5), 10mM MgCl2, 100mM NaCl,
0.1mg/ml BSA) and 100U of HinfI restriction enzyme
(Fermentas). The samples were incubated overnight at
378C after which 50U of T4 DNA ligase (Fermentas) and
rATP (ﬁnal concentration of 0.5mM, Fermentas) were
added. The samples were incubated for 1h at room
temperature and then 2ml of proteinase K (10mg/ml,
Fermentas) was added and the samples were further
incubated overnight at 648C. Finally, the DNA was
recovered by phenol–chloroform extraction followed by
ethanol precipitation and analyzed by PCR using primers
which are listed in Table 3.
Cell transfectionsand luciferase reporter gene assays
HEK-293 and MCF-7 cells were seeded into 6-well plates
(10
5cells/ml) and grown overnight in phenol red-free
DMEM supplemented with 5% charcoal-stripped FBS.
Plasmid DNA containing liposomes were formed
by incubating a reporter plasmid and the expression
vector for human VDR (each 1mg) with 10mg N-[1-(2,3-
dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl-
sulfate (DOTAP, Roth, Karlsruhe, Germany) for 15min
at room temperature in a total volume of 100ml. After
dilution with 900ml phenol red-free DMEM, the lipo-
somes were added to the cells. Here, 500ml of phenol red-
free DMEM supplemented with 15% charcoal-stripped
FBS was added 4h after transfection. At this time, either
100nM 1a,25(OH)2D3 or solvent was also added. The
cells were lysed, 16h after onset of stimulation, using
reporter gene lysis buﬀer (Roche Diagnostics, Mannheim,
Germany). The constant light signal luciferase reporter
gene assay was performed as recommended by the supplier
(Canberra-Packard, Groningen, The Netherlands).
Luciferase activities were normalized with respect to
protein concentration and induction factors were calcu-
lated as the ratio of luciferase activity of ligand-stimulated
cells to that of solvent controls.
RESULTS
ExpressionprofilingofCYP27B1geneexpressioninresponse
to1a,25(OH)2D3
To establish model systems, in which to study the
expression level and the transcriptional responsiveness of
the CYP27B1 gene, we have chosen the cell line HEK-293,
which was derived from a tissue (kidney) where this gene is
known to be regulated by 1a,25(OH)2D3. As a reference,
we took the cell line MCF-7, which is often used to study
1a,25(OH)2D3 signaling, but in which the CYP27B1 gene
is not regulated by 1a,25(OH)2D3. The expression of the
CYP27B1 gene and its response to 1a,25(OH)2D3 was
studied by real-time quantitative PCR (Figure 1A). As a
control, the methyltransferase-like-1 (METTL1) gene,
a direct genomic neighbor of the CYP27B1 gene, was
studied in case the hormone also regulated its transcrip-
tion. Moreover, the levels of the VDIR gene were
examined, because of its key role in the regulation of
CYP27B1 gene (4). Finally, the CYP24 gene, which is
known to be strongly up-regulated in the presence of
1a,25(OH)2D3, was used as a positive control for the
presence of the hormone. In HEK-293 cells, the CYP27B1
mRNA expression was signiﬁcantly down-regulated after
6 and 24h treatment with 1a,25(OH)2D3. In contrast, in
MCF-7 cells, CYP27B1 mRNA expression was not
aﬀected by 1a,25(OH)2D3 treatment. This non-responsive
eﬀect of MCF-7 cells has already been observed before
(32). The expression of METTL1 mRNA did not change
in MCF-7 cells but in HEK-293 cells a transient down
Table 2. PCR primers used in ChIP analysis
Region
No.
Location Primer sequences
1 þ20 to  370 50-CGCGAAAGAAAGCGCTTCTC-30
50-GGGGAATTCCTGAGGATGGG-30
2  350 to  776 50-CCCATCCTCAGGAATTCCCC-30
50-GCTGCTAACCAGAAAGCCCC-30
3  756 to  1278 50-GGGGCTTTCTGGTTAGCAGC-30
50-GAGTTGCAGTGGGGAATGAG-30
4  1258 to  1681 50-CTCATTCCCCACTGCAACTC-30
50-GGACCATAGGGGATCTTTGG-30
5  1661 to  1961 50-CCAAAGATCCCCTATGGTCC-30
50-GTCCTCCAGGCAGTGACCTC-30
6  1941 to  2506 50-GAGGTCACTGCCTGGAGGAC-30
50-GCCTACGTGCTAAGAGTTGG-30
7  2486 to  2885 50-CCAACTCTTAGCACGTAGGC-30
50-GTGTGCAGTGGAACTGTCAC-30
8  2865 to  3090 50-GTGACAGTTCCACTGCACAC-30
50-CATGTATCCTCAGCCCTCCC-30
9  3070 to  3462 50-GGGAGGGCTGAGGATACATG-30
50-GTCCAGTTCTGCCTGGGCAC-30
10  3442 to  3907 50-GTGCCCAGGCAGAACTGGAC-30
50-CTGGTGACATCAGCATGGAG-30
11  3928 to  4444 50-CCATGCTGATGTCACCAG-30
50-CAGGTCAGCGTTTATGGG-30
12  4426 to  5049 50-CCCATAAACGCTGACCTG-30
50-CAGAGGGAGAGAGAGGAG-30
13  5031 to  5433 50-GTCTCGGCTGCCATGATC-30
50-CGAGACCAGGAGTAAGGG-30
Sequences and location relative to the TSS (þ1) are shown.
Table 3. PCR primer sequences used in 3C analysis
Region Location Primer sequences
A  8t o 29 50-CATATCTCAACCCCTATTTAAC -30
B  1652 to  1671 50-GGATCTTTGGAAGGCTGTG-30
C  2661 to  2679 50-CTGGTGGGTTAGGCTGGT-30
D  3222 to  3241 50-GTTCCAGTTCTGCCCCTTC-30
Sequences and location relative to the CYP27B1 gene TSS are shown.
Nucleic Acids Research, 2007, Vol. 35, No. 8 2737regulation at 6h could be observed. VDIR mRNA
expression followed the METTL1 expression in both cell
lines. CYP24 mRNA expression was signiﬁcantly induced
in both cell types.
In order to conﬁrm the dependence of the regulation of
the genes by 1a,25(OH)2D3 on VDR expression, VDR
mRNA levels were inhibited by using speciﬁc siRNA
oligomers (Figure 1B-C). Quantitative real-time PCR
analysis showed that siVDR treatment signiﬁcantly
increased CYP27B1 mRNA expression in HEK-293 cells
but had no eﬀect in MCF-7. For the expression of both
the METTL1 and the VDIR genes, no signiﬁcant
diﬀerences between control siRNA and VDR siRNA-
treated cells could be observed, indicating that the changes
in their mRNA expression (Figure 1A) are probably not
caused by 1a,25(OH)2D3 treatment. When unspeciﬁc
siRNA was used, 1a,25(OH)2D3 was able to up-regulate
CYP24 mRNA expression 3.5-fold in HEK-293 cells and
4000-fold in MCF-7 cells. However, when VDR siRNA
was used, CYP24 mRNA expression stayed at basal levels
in HEK-293 cells and in MCF-7 an 80% decreased ligand
eﬀect was observed.
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Figure 1. Expression proﬁling of the human genes CYP27B1, METTL1, VDIR, and CYP24. Quantitative real-time PCR was performed in order to
study the relative mRNA expression levels of the genes CYP27B1, METTL1, VDIR and CYP24 in HEK-293 and MCF-7 cells and their
responsiveness to 1a,25(OH)2D3 over time (A). The cells were treated with 10nM 1a,25(OH)2D3 for 2, 6 and 24h, prior to the extraction of RNA.
The dependence of the hormone responsiveness of the genes on VDR expression was investigated by RNAi inhibition experiments. For this purpose,
the cells were transfected with unspeciﬁc control siRNA oligomers or with speciﬁc siRNAs against the VDR mRNA. The siRNA treatment time was
72h. Silencing of VDR at protein level was veriﬁed by immunoblotting using whole-cell extracts (B). After siRNA treatment, the cells were further
treated with 10nM 1a,25(OH)2D3 for 3h. The extracted RNA was reverse transcribed and analyzed by quantitative real-time PCR (C). Columns
indicate the means of three independent cell treatments and the tips of the bars represent standard deviations. Two-tailed, paired Student’s t-tests
were performed and P-values (
 P50.05,
  P50.01,
   P50.001) of the fold inductions at the respective time points were calculated in reference to
time-matched vehicle-treated reference (A) or in comparison to transfection with siRNA speciﬁc to VDR mRNA (B).
2738 Nucleic Acids Research, 2007, Vol. 35, No. 8Taken together, the analysis of the CYP24 gene
expression conﬁrms that both HEK-293 and MCF-7
cells have functional VDR-dependent 1a,25(OH)2D3
signaling. However, only in the kidney-derived HEK-293
cells, the CYP27B1 gene is down-regulated by
1a,25(OH)2D3 via the VDR. Finally, the genes METTL1
and VDIR appear not to be primary targets of the VDR.
Scanning the CYP27B1promoter for VDR-binding sites
We scanned in silico the ﬁrst 5.2kb of the human
CYP27B1 promoter for putative VDREs utilizing the
Internet portal NUBIScan (www.nubiscan.unibas.ch) (33)
(Figure 2A). This screening revealed seven DR3-type and
two DR4-type VDREs (Figure 2A). Interestingly, only
one DR3-type VDRE was found within the ﬁrst 1.7kb of
the promoter, to which previous studies were restricted
(4,27–29). This region could be considered as the ‘pure’
promoter of the CYP27B1 gene, since the METTL1 gene
is located only 1.2–5.4kb upstream from its TSS. Thus,
the eight other putative DR3- and DR4-type VDREs are
located within METTL1 gene.
Next we used chromatin from crosslinked
1a,25(OH)2D3-treated HEK-293 and MCF-7 cells, pre-
cipitated it with anti-VDR antibody and used the eluted
chromatin template for a scanning with 13 overlapping
genomic PCR primer pairs covering these 5.4kb of
the human CYP27B1 promoter (Figure 2B and C).
We observed VDR binding to the region of the established
nVDRE (region 2:  350 to  776) but also to
two additional regions located further upstream (region
7:  2486 to  2885 and region 9:  3070 to  3462). All
three regions recruited VDR in a ligand-dependent
fashion, reaching a maximum 120min after onset
of ligand treatment. Interestingly, three of the putative
DR3-type VDREs lay within VDR-binding regions
(Figure 2A).
+
2
0
 
t
o
 
-
3
7
0
−
3
5
0
 
t
o
 
-
7
7
6
−
7
5
6
 
t
o
 
-
1
2
7
8
−
1
2
5
8
 
t
o
 
-
1
6
8
1
−
1
6
6
1
 
t
o
 
-
1
9
6
1
−
1
9
4
1
 
t
o
 
-
2
5
0
6
−
2
4
8
6
 
t
o
 
-
2
8
8
5
−
2
8
6
5
 
t
o
 
-
3
0
9
0
−
3
0
7
0
 
t
o
 
-
3
4
6
2
−
3
4
4
2
 
t
o
 
-
3
9
0
7
−
3
9
2
8
 
t
o
 
-
4
4
4
4
−
4
4
2
6
 
t
o
 
-
5
0
4
9
−
5
0
3
1
 
t
o
 
-
5
4
3
3
A
B
C
METTL1 CYP27B1 
D
R
3
D
R
3
D
R
3
D
R
3
D
R
3
n
V
D
R
E
(
D
R
3
)
2
D
R
4
D
R
4
1 2 3 4 5 6 7 8 9 10 11 12 13
Input
0
30
60
120
180
240
1
α
,
2
5
(
O
H
)
2
D
3
1
α
,
2
5
(
O
H
)
2
D
3
t
r
e
a
t
m
e
n
t
 
t
i
m
e
 
(
m
i
n
)
M
C
F
-
7
Region
t
r
e
a
t
m
e
n
t
 
t
i
m
e
 
(
m
i
n
) Input
0
30
60
120
180
240
H
E
K
-
2
9
3
1 2 3 4 5 6 7 8 9 10 11 12 13
Region
1 2 3 4 5 6 7 8 9 10 11 12 13
Region
Figure 2. Recruitment of VDR to the CYP27B1 promoter. Putative VDR-binding sites were determined by in silico screening by using the net-based
program NUBIScan (33) (A). The analysis revealed nine putative VDREs within 5.4kb upstream from the TSS of the CYP27B1 gene. The gray
cylinders indicate exons of the METTL1 and CYP27B1 genes. The location of PCR products obtained with the genomic primers (Table 2) used
for ChIP assays are indicated above. Ligand-modulated binding of the VDR to these 13 overlapping regions of the human CYP27B1 promoter
was determined on chromatin templates obtained by ChIP assays. For this purpose, chromatin was extracted from HEK-293 (B) and MCF-7
(C) cells that had been treated for the indicated times with 10nM 1a,25(OH)2D3 and precipitation was performed with an anti-VDR antibody.
Representative agarose gels of 4–6 independent experiments are shown.
Nucleic Acids Research, 2007, Vol. 35, No. 8 2739In summary, in living HEK-293 and MCF-7 cells, VDR
binds to three regions within the ﬁrst 5.4kb of the human
CYP27B1 promoter. The proximal region 2 contains the
nVDRE, while the two distal regions 7 and 9 are located
within the METTL gene and carry classical DR3-type
VDREs.
Distal VDREs inthe CYP27B1promoter showdirect VDR
binding
The potential of the nVDRE of region 2, VDRE1 of
region 7 and VDREs 2 and 3 of region 9 (for sequence, see
Figure 3A) to associate with in vitro-translated VDR,
RXR and VDIR (Figure 3B) were compared by gel shift
analysis. The established DR4-type VDRE of the rat Pit-1
gene (34) served as a positive control (Figure 3C). None of
the four classical VDREs bound VDR or RXR alone, but
with the exception of VDRE3 they bound, in a ligand-
dependent fashion, VDR–RXR heterodimers (Figure 3C,
E–G). VDIR bound eﬃciently to the nVDRE (Figure 3D),
but did not interfere with the ligand-dependent VDR–
RXR heterodimer formation on VDRE1, VDRE2 and the
positive control (Figure 3C, E and F). Conversely, VDR
and RXR did not associate on the nVDRE and did not
interfere with VDIR binding to this element, either as
monomers or as heterodimers (Figure 3D). Similarly, an
anti-VDR antibody could not modulate the binding of
VDIR on the nVDRE (Figure 3D), but it reduced the
binding of VDR–RXR heterodimers to VDRE1, VDRE2
and the positive control (Figure 3C, E and F).
Taken together, in vitro, the nVDRE shows only
association with VDIR protein, while VDRE1 and
VDRE2 binds only VDR–RXR heterodimers. VDRE3
does not bind any of these proteins, suggesting that the
binding of VDR to region 9 is mediated by VDRE2.
The ability ofisolated CYP27B1 promoter regions torepress
transcription
The functionality of the genomic regions 2, 7 and 9 of the
human CYP27B1 promoter was examined alone or
together in a large promoter fragment by reporter gene
assays in HEK-293 and MCF-7 cells (Figure 4). As a
positive control, we used the proximal promoter of the
human CYP24 gene that contains a cluster of DR3-type
VDREs. The latter promoter fragment was 6-fold
inducible by 1a,25(OH)2D3 in HEK-293 cells and
showed even a 30-fold inducibility in MCF-7 cells. In
HEK-293 cells the basal activity of regions 2, 7 and 9 of
the CYP27B1 promoter was reduced by 15–40% by
1a,25(OH)2D3 treatment, but only the reductions of
regions 2 and 9 were found to be statistically signiﬁcant
(Figure 4A). The large CYP27B1 promoter fragment
containing all three regions was even 450% reduced. In
contrast, in MCF-7 cells, none of the four CYP27B1
promoter constructs showed any signiﬁcant response to
stimulation with 1a,25(OH)2D3 (Figure 4B).
In summary, this analysis of the activity of the
CYP27B1 promoter parallels to the observation made
on the level of mRNA expression (Figure 1), in that only
in HEK-293 cells but not in MCF-7 cells, can a down-
regulation by 1a,25(OH)2D3 be found. Interestingly, not
only region 2 of the CYP27B1 promoter, which contains
the characterized nVDRE, supports this down-regulation
but also region 9 (in which VDRE2 resides).
Ligand-dependent association of cofactorproteins with
CYP27B1 promoter regions
To further characterize the role of the CYP27B1 gene
promoter regions 2, 7 and 9, we performed an extensive
ChIP analysis with antibodies against multiple VDR
partner proteins in HEK-293 and MCF-7 cells
(Figure 5). Region 6 of the CYP27B1 promoter, which
does not contain a VDRE, served as a negative control
and a region covering the proximal promoter of the
CYP24 gene including its VDRE cluster was the positive
control. In addition to VDR and RXR, the proteins were
chosen to represent general chromatin activity (AcH3 and
AcH4), gene activation (the CoAs SRC-1, SRC-2, SRC-3,
CBP and pPolII) and gene repression (Sin3A and the
CoRs SMRT and NCoR). At the three VDRE-containing
regions of the CYP27B1 promoter and in both cell types
the acetylation level of histone H3 decreased in response
to 1a,25(OH)2D3 treatment, while on the proximal
promoter of the CYP24 gene it signiﬁcantly increased.
However, at all four VDRE-containing regions the histone
H4 acetylation level increased after ligand treatment.
In both cell types, VDR and RXR were associated
ligand-dependently with the three VDRE-containing
regions and the CYP24 region, but not with the negative
control region 6. The recruitment of HAT CBP, whose
main substrate is the histone H3 tail, mirrored the changes
in the histone H3 acetylation levels with the exception of
the proximal promoter of the CYP24 gene in HEK-293
cells, which did not bind CBP. In both cell types, pPolII
associated strongly with the region 2 (containing the
nVDRE) and reduced its binding after ligand treatment.
Interestingly, in HEK-293 cells the same observation was
made with region 7 (containing VDRE1), while in MCF-7
cells pPolII remained associated with the region even after
ligand treatment. In both cell lines, region 9 and the
negative control did not show any binding of PolII, while
the proximal promoter of the CYP24 gene demonstrated
strong ligand-dependent recruitment of the polymerase.
The association of CoAs of the p160 family with
diﬀerent regions signiﬁcantly diﬀered in HEK-293 and
MCF-7 cells. After ligand treatment in MCF-7 cells, SRC-
1, SRC-2 and SRC-3 were recruited to the proximal
CYP24 promoter, while in HEK-293 cells this was the case
only for SRC-1 and SRC-3. In HEK-293 cells, SRC-1 and
SRC-3 bound only to region 2 of the CYP27B1 promoter
(and not to regions 6, 7 and 9) and dissociated from it
after ligand stimulation. In contrast, in MCF-7 cells, SRC-
1 bound constitutively to regions 2 and 7 (and not to
region 9), while SRC-3 was strongly recruited by ligand
treatment to regions 7 and 9 and in parallel partially
dissociated from region 2.
In both cell lines, Sin3A bound constantly to region 2
through the time points analyzed and in HEK-293 cells,
also to regions 7 and 9. After ligand stimulation, Sin3A
dissociated in both cell lines from the proximal promoter
fragment of the CYP24 gene, while in parallel, in MCF-7
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Figure 3. Recruitment of VDR–RXR heterodimers and VDIR to the VDREs found in the CYP27B1 gene promoter. Sequence and location of
VDREs within the human CYP27B1 promoter (A). The hexameric core motifs within the DR3-type VDREs and the E-boxes within the nVDRE are
shown in bold. Eﬃciency of in vitro translation of VDR, RXR and VDIR was examined by using
35S-labeled proteins that were analyzed on a 12%
denaturing polyacrylamide gel (B). Gel shift experiments were performed with in vitro-translated VDR, RXR and VDIR proteins in the presence or
absence of 1mM1 a,25(OH)2D3 on the established DR4-type VDRE of the rat pit-1 gene (core sequence 50-gaAGTTCAtgagAGTTCA-30, C), the
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The latter were resolved from free probe through 8% non-denaturing polyacrylamide gels. Representative gels are shown.
Nucleic Acids Research, 2007, Vol. 35, No. 8 2741cells, it was recruited to region 7 and not at all to region 9.
The CoR, SMRT was recruited by ligand in both cell lines
to regions 2 and 7 and dissociated from the proximal
CYP24 promoter region. SMRT was in HEK-293 cells
and was also recruited to region 9, a phenomenon not
observed in MCF-7-cell-derived chromatin templates.
Finally, in HEK-293 cells, after ligand treatment,
NCoR1 was recruited to regions 2, 7 and 9, while in
MCF-7 cells it was only recruited to region 7 and in
parallel dissociated from regions 2 and 9. In both cell lines,
NCoR1 dissociated from the proximal CYP24 promoter.
Taken together, the ligand-dependent association and
dissociation of cofactor proteins to the three VDR-
binding regions of the CYP27B1 promoter, in particular
the CoAs SRC-1 and SRC-3 and the CoR, NCoR1, show
signiﬁcant diﬀerences between HEK-293 and MCF-7 cells.
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Figure 4. Functional analysis of the VDR-associated regions in the CYP27B1 promoter. Regions 2, 7 and 9 of the human CYP27B1 promoter were
cloned alone or together (as found in the human genome) in front of thymidine kinase (tk) promoter driving the luciferase (Luc) gene. The proximal
promoter of the human CYP24 gene containing a cluster of DR3-type VDREs was used as a positive control and the empty reporter vector
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(B) cells. Luciferase activity was determined after 16h 1a,25(OH)2D3 treatment. Columns indicate the means of three independent experiments
and the tips of the bars represent standard deviations. Two-tailed, paired Student’s t-tests were performed and P-values (
   P50.001) of the fold
inductions were calculated in reference to vehicle-treated controls.
2742 Nucleic Acids Research, 2007, Vol. 35, No. 8This may explain the diﬀerential transcriptional response
of the CYP27B1 gene in both cell lines to stimulation with
1a,25(OH)2D3.
Connectivity ofthedistal andproximal VDR-binding regions
of theCYP27B1 promoter
We used 3C assays in order to investigate, whether the
distal regions 7 and 9 of the human CYP27B1 promoter
are directly connected with region 2 containing the
nVDRE and/or region 1 including the TSS (Figure 6).
The restriction enzyme HinfI was used to digest major
parts of the DNA loops between the binding sites of
genomic primers on the TSS (A), a control site (B),
VDRE1 (C) and VDRE2/3. Under no conditions was a
PCR product obtained with the genomic primers A and B,
indicating that the control region was not looping to the
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Nucleic Acids Research, 2007, Vol. 35, No. 8 2743TSS. In contrast, in MCF-7 cells VDRE1 containing-
region (region 7) was ligand-dependently connected with
proximal region (PCR fragment obtained by primers A
and C) containing both the nVDRE and the TSS, while in
HEK-293 cells this DNA looping occurred even in the
absence of ligand. Moreover, only in HEK-293 cells
VDRE2/3-containing region (region 9) looped ligand-
dependently to the TSS and the nVDRE (PCR fragment
obtained by primers A and D).
In summary, the 3C analysis indicated that in HEK-293
cells DNA looping between regions 1/2 and regions 7 and
9 takes place suggesting that the VDREs in these regions
may act synergistically. Moreover, in HEK293 cells
speciﬁcally, region 9 interacted with regions 1/2 only in
the presence of hormone. This together with our previous
reporter gene analysis indicates that region 9 contains a
functional vitamin D-dependent repressor that is able to
act together with the TSS/nVDRE-containing region to
repress gene transcription. In contrast, in MCF-7 cells
only a connection between regions 1/2 and region 7 was
observed and this did not lead to gene repression.
DISCUSSION
The mechanism of negative gene regulation by nuclear
receptors is still poorly understood, but the human
CYP27B1 gene and its down-regulation in the presence
of 1a,25(OH)2D3 may be so far the most detailed model
(4). Since the model takes account only the proximal
promoter of the CYP27B1 gene, we aimed in this study to
test the hypothesis that also in the case of gene repression
multiple response elements located in more distal regions
may be involved in the regulation.
The distance between the TSSs of the neighboring genes
CYP27B1 and METTL1 is only 5.4kb (Figure 2A), with
the METTL1 gene being read in the same direction as
CYP27B1 (its last exon ends only 1.2kb upstream of the
TSS of the CYP27B1gene). Thus, the promoter of
CYP27B1 seems to be only 1.2kb in size. Indeed, the
studies of human and mouse CYP27B1 promoters have so
far considered only the ﬁrst 1.7kb upstream from the TSS
of CYP27B1 (4,27–29). Therefore, it is interesting that the
combined results of our in silico screening and promoter
ChIP scanning suggested that within the studied
CYP27B1 promoter region, two additional VDREs,
located in regions 7 and 9 (being within introns of the
METTL1 gene) upstream from region 2 carrying the
nVDRE. According to our ChIP scanning of the
CYP27B1 promoter, the time-dependent binding proﬁle
of VDR was similar both in MCF-7 cells and HEK-293
cells with one exception. In HEK-293 cells, the VDR
seemed to associate with the described CYP27B1 gene
TSS stronger than in MCF-7 cells (Figure 2). Since region
1 possesses neither an nVDRE nor a regular VDRE, this
may suggest that the protein bridge exists between the
VDR-binding regions and the TSS in HEK-293, but not in
MCF-7 cells.
According to Murayama and colleagues (4), the
association of the VDR–RXR heterodimer to the
nVDRE is not a direct binding to DNA, but occurs via
the transcription factor VDIR. We found that in vitro-
translated VDR–RXR heterodimers cannot bind to the
nVDRE although in vitro-translated VDIR can (Figure 3).
Interestingly, with the distal VDREs, reasonable VDR–
RXR heterodimer association could be observed with
VDRE1 and VDRE2 from regions 7 and 9, respectively.
This did not apply to the neighboring VDRE3, suggesting
that VDR is associated only with VDRE2 within region 9.
The binding of the VDR–RXR complex to VDRE1 and
VDRE2 was ligand dependent, but contrary to that of
nVDRE, the binding may involve direct interactions with
DNA sequences. Therefore, the new distal VDREs
resemble positive VDREs, as has been previously
described for most of the negative VDREs identiﬁed so
far (10–12).
A reporter gene analysis of diﬀerent CYP27B1 promo-
ter fragments (Figure 4) showed that both the regions
containing the nVDRE and VDRE2/3 were able to repress
gene activity in HEK-293 cells, but not in MCF-7 cells. In
addition, a longer promoter fragment including both the
nVDRE and VDRE2/3, an even more signiﬁcant repres-
sion was achieved. Therefore, our results suggest that both
nVDRE and VDRE2/3 are eﬃcient negative regulators of
the CYP27B1 promoter and work in HEK-293 cells
together in the repression of CYP27B1 gene expression.
Our ChIP data suggested that the acetylation level of
histone H3 tails was decreased in both cells in response to
1a,25(OH)2D3 (Figure 5). Interestingly, although the
histone H3 acetylation levels decreased, the chromatin
did not change to completely non-permissive form,
because the acetylation status of the histone H4at all
regions remained constant or even increased after the
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2744 Nucleic Acids Research, 2007, Vol. 35, No. 8addition of 1a,25(OH)2D3. The acetylation level of histone
H3at control region remained constantly high and
acetylation level of histone H4 increased. This suggests
that a wide area of chromatin of distal CYP27B1
promoter is permissive in both cells in the absence of
ligand, which may be related to the high basal activity
of CYP27B1 gene. Addition of ligand results in local
deacetylation of regions 7 and 9 together with region
2 thus leading to repression. Neither of these histone
acetylation patterns is able to describe the cell-type-
selective repression described here. However, it is possible
that other forms of histone marking such as methylation,
acting alone or in combination with the histone acetyla-
tion may be involved. It is also possible that tissue-
selective factors may have to be present.
In both cell types, diﬀerent transcription factors were
associated with the nVDRE in a very similar fashion
(Figure 5). Signiﬁcant diﬀerences could be observed in the
recruitment of pPolII, the CoAs SRC-1 and SRC-3 and
the CoR NCoR. In MCF-7 cells, the VDRE1-containing
region seemed to favor interactions with CoAs more than
in HEK-293 cells. Contrary to this, the region containing
VDRE2/3 seemed to recruit CoRs more eﬃciently in
HEK-293 cells than in MCF-7 cells. One possible
explanation is that the diﬀerent cell lines possess diﬀering
levels of distinct cofactors. According to the GNF
SymAtlas database (35), MCF-7 and HEK-293 cells
diﬀer signiﬁcantly from each other with respect to
expression of SRC-1, SRC-3, NCoR1 and HDAC2,
where the respective CoAs are expressed more in MCF-7
cells, whilst NCoR1 and HDAC2 are more abundant in
HEK-293 cells. Thus it is possible that, although the
CYP27B1 promoter is similarly permissive in both cell
types, concerning the binding of transcription factors, the
repression of the gene is reached only in HEK-293 cells,
because some important transcription factors are missing
in MCF-7 cells. This could explain, at least in part, our
ChIP data. Interestingly, the binding proﬁles of transcrip-
tion factors at diﬀerent regions were very similar,
especially in HEK-293 cells. This suggests that it is
possible that diﬀerent regions may be connected with
each other via chromatin looping and therefore the output
of single antibody ChIP analysis of the distal and
proximal regions actually represents the same super
complex of transcription factors.
This hypothesis is supported by the fact that our 3C
analysis conﬁrmed that the proximal and distal regions of
the human CYP27B1 gene promoter are in contact with
each other (Figure 6). From the results, it can be observed
that in MCF-7 cells region 7 (containing VDRE1) is
connected to the region containing the TSS in a ligand-
dependent manner, but the region containing VDRE2/3
does not form any similar connections. In contrast to this,
in HEK-293 cells, regions encompassing both VDRE1 and
VDRE2/3 were connected with a region containing the
TSS of the CYP27B1 gene. The connection between the
VDRE1-containing region and the proximal promoter
was present both in the absence and in the presence of
ligand. However, the most striking result was that
VDRE2/3-containing region was only in contact with
the proximal promoter when 1a,25(OH)2D3 was present.
This suggests that VDRE1-containing region seems to be
related more with basal (positive) transcriptional activity
and that the VDRE2/3-containing region may have an
important role in transcriptional repression. Please note
that because there were no restriction-enzyme-cutting sites
between the nVDRE and the TSS, it was impossible to
determine exactly if VDRE1 or VDRE2/3 are connected
to the nVDRE or TSS or both. In this case, the 3C
analysis only reveals that the distal regions are connected
with the proximal region that contains both the nVDRE
and TSS.
In the light of our results presented here, we propose a
model that may explain the role of distal VDREs in the
transcriptional regulation of CYP27B1 gene in HEK-293
cells (Figure 7). When the gene is active, chromatin
looping brings the distal region, which includes VDRE1,
close to the proximal promoter. Both regions associate
with a common super complex of transcription factors
that is broadly transcriptionally positive and includes
CoAs such as SRC-1, SRC-2, SRC-3 and CBP. The
nVDRE is connected via VDIR, but the anchoring
transcription factor at VDRE1 is presently unknown.
VDRE2/3
RXR
NCoR
Sin3A
+ 1a,25(OH)2D3
RNA PolII
CBP
CYP27B1
CYP27B1
SRC-1
Active
Repressed
Sin3A
X
VDIR
SRC-3
VDR
SRC-2
SRC-2
SRC-2
NCoR
CBP
SRC-1
SRC-3
CBP
RNA PolII
RXR
VDR
X
Sin3A
NCoR
SMRT
SMRT
VDRE1 nVDRE
CYP27B1
X
VDRE2/3
VDRE1
VDIR
nVDRE
VDRE2/3
VDRE1
VDRRXR
RXR
VDR
nVDRE
Figure 7. A model representing the crosstalk of distal and prox-
imal promoter regions during the transcriptional regulation of the
CYP27B1 gene.
Nucleic Acids Research, 2007, Vol. 35, No. 8 2745We cannot either exclude the possibility that the ligand-
independent looping happens via some other element that
locates close to VDRE1. The HAT activity of CBP
acetylates the histone H3 tails and thus keeps the
chromatin at proximal promoter permissive for basal
transcriptional machinery including pPolII. The region
containing VDRE2/3 on the other hand is not involved in
the transcriptional activation of the CYP27B1 gene as can
be inferred from its non-connectedness to the TSS-
containing region in MCF-7 cells. However, it seems to
recruit several transcription factors including repressive
proteins, which are missing from the super complex
associated with the nVDRE- and VDRE1-containing
chromatin regions, selectively in HEK-293 cells. This
suggests that a diﬀerent complex is bound to this region,
but the purpose of this complex is presently unknown as
well as how the protein complex is associated with the
region containing VDRE2/3. The addition of
1a,25(OH)2D3 results in the modulation of the super
complex where activating transcription factors are
replaced with repressing proteins. At the same time, the
chromatin architecture changes and chromatin looping
locates VDRE2/3 close to proximal promoter allowing it
to associate with a common repressive super complex
together with nVDRE and VDRE1.
In conclusion, we have revealed that the responsiveness
of the CYP27B1 gene to 1a,25(OH)2D3 is a cell-type-
selective event that involves diﬀerent combinations of
multiple VDREs that act to recruit and interact with
protein super complexes of diﬀering transcriptional
abilities. It is hoped that this work will allow us to
understand better gene repression by nuclear receptors in
general and the tissue-selective nature of the CYP27B1
gene repression by 1a,25(OH)2D3 speciﬁcally.
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